National
Top 10 national news stories of 2022
From Club Q to monkeypox to midterm surprises, a year to remember
The year 2022 will be remembered for a slew of LGBTQ-related news. As if COVID wasn’t bad enough, the arrival of monkeypox in the spring led to a new panic and new round of vaccinations among gay and bi men. There was the overturning of Roe and fears of attacks on Obergefell. Then came the midterms and the Democrats ran surprisingly strong. And just when we thought the year was over, five LGBTQ people were shot to death at Club Q and Congress managed to pass the Respect for Marriage Act.
Below are the Blade’s staff picks for the top 10 stories of 2022.
#10 Karine Jean-Pierre makes history
Karine Jean-Pierre made history this year, becoming the first Black and the first LGBTQ White House press secretary, having previously served as deputy press secretary to Jen Psaki and chief of staff for then-vice-presidential candidate Kamala Harris.
When Jean-Pierre gave her first White House press briefing last year, on an Air Force One flight bound for Atlanta, she became the first LGBTQ person to do so. Jean-Pierre is also an immigrant born in Martinique, France, to Haitian parents.
#9 Turmoil and change at HRC
Alphonso David’s tenure as the first Black president of the Human Rights Campaign came to an end in 2021 following accusations that David, when serving as counsel to then-New York Gov. Andrew Cuomo, helped to cover up allegations that the politician had sexually harassed and assaulted multiple women. After stepping down from HRC, David filed a lawsuit against the organization alleging discrimination.
On Nov. 28, 2022, Kelley Robinson took over as HRC president, becoming the first Black queer woman to lead the nation’s largest LGBTQ advocacy organization. A veteran community organizer who previously served as executive director of Planned Parenthood Action Fund, Robinson told the Blade she is committed to leading HRC with a focus on intersectionality.
#8 U.S. declares monkeypox public health emergency
In August, the Centers for Disease Control and Prevention declared the monkeypox virus (MPV) outbreak a public health emergency in the United States. Cases by then had been reported in all 50 states, the District of Columbia, and Puerto Rico – almost all by gay and bisexual men who have sex with men.
Initially, the Biden-Harris administration’s vaccination campaign, which involved transporting doses from the Strategic National Stockpile to clinics across the country, was widely criticized as too slow, with problems that carried over from the government’s shaky rollout of tests and vaccines for COVID-19.
By midsummer, however, more shots were being administered in more arms thanks to a coordinated effort by the White House Pandemic Office. The number of MPV cases declined from a peak of 440 per day in August to 60 in October.
#7 Ketanji Brown Jackson joins Supreme Court
Ketanji Brown Jackson began her tenure as the first Black woman to serve as a justice on the U.S. Supreme Court, having previously presided over the U.S. Court of Appeals for the District of Columbia Circuit.
Before Jackson was seated this summer, the Supreme Court’s conservative supermajority overturned the constitutional right to abortion with its ruling in Dobbs v. Jackson Women’s Health Organization.
This term, the Supreme Court will decide 303 Creative v. Elenis, a case that was brought by a web designer who wanted to reject same-sex couples’ requests for wedding websites and whose outcome could carry broad implications for the enforcement of nondiscrimination laws against providers of public accommodations.
#6 Schools become nexus of battles over LGBTQ rights
As conservative state legislators ramped up attacks on the LGBTQ community with bills targeting youth sports and policies in public schools, right-wing advocates and hate groups increasingly protested all-ages LGBTQ events like family-friendly drag performances and drag queen story hours – often carrying firearms and occasionally causing enough disruption that organizers and patrons were forced to disperse.
From Virginia to Minnesota to Florida, schools were embroiled this year over battles like whether educational materials containing LGBTQ themes should be made available to students and whether LGBTQ students should be outed to their parents.
Critics of Florida’s “Don’t Say Gay” law said it was written with discriminatory intent, warning teachers could be penalized for something as innocuous as displaying a photo of their same-sex spouse.
#5 Record number of anti-trans bills filed across country
More anti-trans bills were proposed this year in state legislatures throughout the country than during any other time in the nation’s history. Most targeted trans youth.
Some laws prohibit trans student athletes from playing and competing, while others restrict access to bathrooms and locker rooms that align with their gender identities and others target guideline directed medical treatments.
Texas Governor Greg Abbott, for example, directed child welfare authorities to investigate suspected cases where parents made gender affirming healthcare available to their trans and nonbinary children.
#4 Pelosi steps down from leadership after husband attacked
House Speaker Nancy Pelosi (D-Calif.) announced her plans to step down from House Democratic leadership after two decades, following the attack on her husband Paul Pelosi by an intruder who broke into the couple’s San Francisco home.
The first woman ever elected to become Speaker, Pelosi has been called the most effective lawmaker to ever serve in that role. Under the administrations of four presidents over two decades, she boasted signature legislative accomplishments like the passage of the Affordable Care Act and repeal of “Don’t Ask, Don’t Tell.” Rep. Hakeem Jeffries (D-N.Y.) was elected to succeed her.
#3 Midterms deliver Trump rebuke, victories for LGBTQ candidates
Political observers were surprised by Democrats’ expanded Senate majority and Republicans’ narrow capture of the House following the 2022 midterm elections, which were expected to hand the GOP decisive control of both chambers of Congress.
Not all Democratic candidates were so fortunate, however. Gay New York Rep. Sean Patrick Maloney (N.Y.), for instance, failed to win reelection despite his position as chair of the Democratic Congressional Campaign Committee, the party’s sixth highest-ranking position in the House.
Meanwhile, the LGBTQ Victory Fund reports that a record-breaking number of LGBTQ candidates ran for and were elected to public office – more than 340 and 1,065, respectively.
#2 Club Q shooting and fallout
On Nov. 19, the eve of the Transgender Day of Remembrance, a gunman opened fire in Club Q, a Colorado Springs LGBTQ nightclub, killing five people and wounding 17 others in the deadliest attack on LGBTQ people since the Pulse nightclub shooting in Orlando in 2016.
The suspect, who was tackled and disarmed by patrons, including a trans woman, was charged with 305 criminal counts including hate crimes and murder.
The tragedy ignited a conversation about the link between hateful anti-LGBTQ rhetoric and actual violence directed at the community.
#1 Respect for Marriage Act becomes law
The Respect for Marriage Act, widely considered the greatest legislative victory for LGBTQ rights since the repeal of “Don’t Ask, Don’t Tell” in 2011, was passed by Congress with little time to spare before the end of the legislative session and promptly signed into law by President Joe Biden on Dec. 13.
Should the U.S. Supreme Court overturn or substantially weaken the constitutional right to same-sex marriage, the Respect for Marriage Act will gird against some of the greatest harms that would result for same-sex couples in the United States. Supreme Court Justice Clarence Thomas signaled his plan to revisit the high court’s caselaw governing marriage – along with other fundamental rights – in his concurring opinion in Dobbs v. Jackson Women’s Health Organization, a case whose ruling this summer overturned federal protections for abortion that had been in place since Roe v. Wade was decided in 1973.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
